Abstract:Therapeutic approaches based on nanomedicine have garnered great attention in cancer research. In vitro biological models that better mimic in vivo conditions are crucial tools to more accurately predict their therapeutic efficacy in vivo. In this work, a new 3D breast cancer microtissue has been developed to recapitulate the complexity of the tumor microenvironment and to test its efficacy as screening platform for drug delivery systems. The proposed 3D cancer model presents human breast adenocarcinoma cells and cancer-associated fibroblasts embedded in their own ECM, thus showing several features of an in vivo tumor, such as overexpression of metallo-proteinases (MMPs). After demonstrating at molecular and protein level the MMP2 overexpression in such tumor microtissues, we used them to test a recently validated formulation of endogenous MMP2-responsive nanoparticles (NP). The presence of the MMP2-sensitive linker allows doxorubicin release from NP only upon specific enzymatic cleavage of the peptide. The same NP without the MMP-sensitive linker and healthy breast microtissues were also produced to demonstrate NP specificity and selectivity. Cell viability after NP treatment confirmed that controlled drug delivery is achieved only in 3D tumor microtissues suggesting that the validation of therapeutic strategies in such 3D tumor model could predict human response. Statement of significance: A major issue of modern cancer research is the development of accurate and predictive experimental models of human tumors consistent with tumor microenvironment and applicable as screening platforms for novel therapeutic strategies. In this work, we developed and validated a new 3D microtissue model of human breast tumor as a testing platform of anti-cancer drug delivery systems. To this aim, biodegradable nanoparticles responsive to physiological changes specifically occurring in tumor microenvironment were used. Our findings clearly demonstrate that the breast tumor microtissue well recapitulates in vivo physiological features of tumor tissue and elicits a specific response to microenvironmentally-responsive nanoparticles compared to healthy tissue. We believe this study is of particular interest for cancer research and paves the way to exploit tumor microtissues for several testing purposes.

A Novel 3D Breast-Cancer-on-chip Platform for Therapeutic Evaluation of Drug Delivery Systems.

Metastasis-on-a-chip Mimicking the Progression of Kidney Cancer in the Liver for Predicting Treatment Efficacy

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Bioprinting of Novel 3D Tumor Array Chip for Drug Screening

Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

3D tumor microtissues as an in vitro testing platform for microenvironmentally-triggered drug delivery systems

Evaluation of a targeted drug delivery system on breast tumor spheroids on a chip

A novel tissue-engineered 3D tumor model for anti-cancer drug discovery.

Application of a Microfluidic Chip-Based 3D Co-Culture to Test Drug Sensitivity for Individualized Treatment of Lung Cancer.

Establishment and large-scale validation of a three-dimensional tumor model on an array chip for anticancer drug evaluation

Establishment of an in Vitro Three-Dimensional Vascularized Micro-Tumor Model and Screening of Chemotherapeutic Drugs

Near-physiological Microenvironment Simulation on Chip to Evaluate Drug Resistance of Different Loci in Tumour Mass.

Recapitulation of dynamic nanoparticle transport around tumors using a triangular multi-chamber tumor-on-a-chip

3D Collagen Microchamber Arrays for Combined Chemotherapy Effect Evaluation on Cancer Cell Numbers and Migration.

In vitro vascularized liver and tumor tissue microenvironments on a chip for dynamic determination of nanoparticle transport and toxicity

A Novel 3-D Bio-Microfluidic System Mimicking in Vivo Heterogeneous Tumour Microstructures Reveals Complex Tumour-Stroma Interactions.

An Integrated Microfluidic 3D Tumor System for Parallel and High-Throughput Chemotherapy Evaluation

Mimicking 3D breast tumor-stromal interactions to screen novel cancer therapeutics

Microsphere‐Enabled Modular Formation of Miniaturized In Vitro Breast Cancer Models

A novel design of microfluidic platform for metronomic combinatorial chemotherapy drug screening based on 3D tumor spheroid model

A Tumor‐on‐a‐Chip System with Bioprinted Blood and Lymphatic Vessel Pair